2658-6533Research Results in Biomedicine2658-653310.18413/2658-6533-2022-8-2-0-52744Pharmacology<strong>Pharmacological characteristics of intranasal dosage forms containing Ginkgo biloba extracts</strong><strong>Pharmacological characteristics of intranasal dosage forms containing Ginkgo biloba extracts</strong>KovtunElena V.KovtunElena V.elena.f.73@mail.ruStepanovaEleonora F.StepanovaEleonora F.efstepanova@yandex.ruChernikovMaxim V.ChernikovMaxim V.pharmax@list.ruPozdnyakovDmitrij I.PozdnyakovDmitrij I.pozdniackow.dmitry@yandex.ruShabanovaNatalia B.ShabanovaNatalia B.Vahlushina@mail.ruGerashchenkoAnastasia D.GerashchenkoAnastasia D.anastasia_gerashchenko@mail.ruPogrebnyakLyudmila V.PogrebnyakLyudmila V.lyupin@yandex.ruTworowskyDmitryTworowskyDmitrydmitwor@gmail.com20228200

Background: This article reviews the pharmacological characteristics of developed dosage forms for intranasal administration. The influence of the type of dosage form on the efficacy of the drug is significant. Gel-like structures are interesting objects for research. Interest in understanding the nature and properties of such structures is due to the variety of effects observed when gels are used. The active ingredient in the studied forms is ginkgo biloba extract obtained by ultrasonic extraction followed by thickening. The object of comparison is standardized dried ginkgo biloba extract (EGB 76). The study of cerebrotropic activity of the developed gels was conducted on the model of bilateral occlusion of the common carotid arteries. The studied objects and the reference preparation were administered therapeutically after modeling cerebral ischemia once a day for 3 weeks. Aim of the study: To evaluate specific pharmacological activity of the developed dosage forms of ginkgo biloba. Materials and Methods: Studies were performed in an appropriate design by simulating cerebral ischaemia in rabbits using simultaneous bilateral occlusion of the common carotid arteries. Changes in cerebral blood flow velocity were performed by Doppler using an appropriate transducer and software package. The data obtained were statistically processed using an application software package. Results: Conducted investigations revealed that under conditions of experimental cerebral ischemia simulated by simultaneous occlusion of the common carotid arteries in large laboratory animals (rabbits), the use of the developed dosage forms promoted the reduction of the severity of neurological deficit, the restoration of cerebral hemodynamics and pro/antioxidant balance in the hippocampus. Conclusions: Developed nasal gels based on chitosan and sodium alginate are promising agents for chronic cerebrovascular accident with antioxidant mechanism of action and therapeutic potential similar to oral administration of standardized ginkgo biloba extract - EGB 761

Background: This article reviews the pharmacological characteristics of developed dosage forms for intranasal administration. The influence of the type of dosage form on the efficacy of the drug is significant. Gel-like structures are interesting objects for research. Interest in understanding the nature and properties of such structures is due to the variety of effects observed when gels are used. The active ingredient in the studied forms is ginkgo biloba extract obtained by ultrasonic extraction followed by thickening. The object of comparison is standardized dried ginkgo biloba extract (EGB 76). The study of cerebrotropic activity of the developed gels was conducted on the model of bilateral occlusion of the common carotid arteries. The studied objects and the reference preparation were administered therapeutically after modeling cerebral ischemia once a day for 3 weeks. Aim of the study: To evaluate specific pharmacological activity of the developed dosage forms of ginkgo biloba. Materials and Methods: Studies were performed in an appropriate design by simulating cerebral ischaemia in rabbits using simultaneous bilateral occlusion of the common carotid arteries. Changes in cerebral blood flow velocity were performed by Doppler using an appropriate transducer and software package. The data obtained were statistically processed using an application software package. Results: Conducted investigations revealed that under conditions of experimental cerebral ischemia simulated by simultaneous occlusion of the common carotid arteries in large laboratory animals (rabbits), the use of the developed dosage forms promoted the reduction of the severity of neurological deficit, the restoration of cerebral hemodynamics and pro/antioxidant balance in the hippocampus. Conclusions: Developed nasal gels based on chitosan and sodium alginate are promising agents for chronic cerebrovascular accident with antioxidant mechanism of action and therapeutic potential similar to oral administration of standardized ginkgo biloba extract - EGB 761

intranasal dosage formsginkgo biloba extractcerebrotropic activityintranasal dosage formsginkgo biloba extractcerebrotropic activityСписок литературыNash KM, Shah ZA. Current Perspectives on the Beneficial Role of Ginkgo biloba&nbsp; in Neurological and Cerebrovascular Disorders. Integrative Medicine Insights. 2015;10:1-9. DOI: https://doi.org/10.4137/IMI.S25054Korchagin DV, Kurkina AV, Dubishchev AV, et al. Study of neurotropic activity of drugs based on ginkgo leaves of bilobate. Fundamentalnye issledovaniya [Fundamental research]. 2013;10-4:812-815. Russian.Wang N, Chen X, Geng D, et al. Ginkgo biloba&nbsp; leaf extract improves cognitive abilities of rats with dementia caused by D-galactose. Journal of Biomedical Research. 2013;27(1):29-36. DOI: https://doi.org/10.7555/JBR.27.20120047du Cert NP, Hurst V, Ahluwalia A, et al. The ARRIVE 2.0 Guidelines: Updated guidelines for reporting on animal research. PLoS Biology. 2020;18(7):e3000410. DOI: https://doi.org/10.1371/journal.pbio.3000410Lee D, Miwa Y, Jung H, et al. A Murine Model of Ischemic Retinal Injury Induced by Transient Bilateral Common Carotid Artery Occlusion. Journal of Visualized Experiments. 2020;165. DOI: https://doi.org/10.3791/61865McGraw CP, Pashayan AG, Wendel OT. Brain infarction in the Mongolian gerbil, aggravated by treatment with phenoxybenzamine. Stroke. 1976;7(5):485-488. DOI: https://doi.org/10.1161/01.STR.7.5.485Tyurenkov IN, Voronkov AV, Dorkina EG. The effect of hesperidin and flavicin on hepatic blood flow in normal conditions and under conditions of stimulation and blockade of the synthesis of endogenous nitric oxide. Regional blood circulation and microcirculation. 2006;5(3):84-87. Russian.Chumakov VN, Osinskaya LF. Quantitative method for determining the activity of zinc, copper-dependent superoxide dismutase in biological material. Voprosy meditsinskoy khimii. 1977;5:712-716. Russian.Kilkopf KL, Bauer W, Urbach IL. Bradford analysis for determining protein concentration. Cold Spring Harbor Protocols. 2020;2020(4):102269. DOI: https://doi.org/10.1101/pdb.prot102269Stalnaya ID, Garishvili TG. Method for determining malondialdehyde using TBK / / Modern methods in biochemistry. Moscow: Meditsina; 1977. Russian.Rahman I, Kode A, Biswas SK. Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method. Nature Protocols. 2006;1:3159-3165. DOI: https://doi.org/10.1038/nprot.2006.378Farkas E, Luiten PG, Bari F. Permanent bilateral occlusion of the common carotid artery in a rat: a model of chronic neurodegenerative diseases associated with brain hypoperfusion. Brain Research. 2007;54(1):162-80. DOI: https://doi.org/10.1016/j.brainresrev.2007.01.003